Healthcare Sector TradingBiotech's Commercial Inflection Point: Regeneron, Moderna, CRISPR Therapeutics, and REGENXBIO Approach Revenue-Generating ThresholdViaNews Editorial Team (Markets)•Feb 18, 2026
TechnologyFDA Delays Review of Moderna's Influenza Vaccine ApplicationViaNews Editorial Team (Markets)•Feb 11, 2026
